Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Cash flows from operating activities:
Net income	$ 49,018	$ 175,902	$ 173,975
Adjustments to reconcile net income to net cash provided by operating activities
Stock-based compensation	29,635	26,539	24,148
Depreciation and amortization	33,437	20,010	15,501
Amortization of debt issuance costs	1,176	0	0
(Gain)/loss on disposal of fixed assets	(150)	112	204
Impairment of intangibles	6,300	10,335	6,520
Deferred taxes	(4,669)	(4,703)	6,105
Loss on divestiture of business	0	3,199	0
Accrued interest on note receivable – related party	0	0	8
Note receivable - related party	0	0	409
Change in valuation of contingent payment liability	(5,580)	2,722	0
Amortization of inventory step-up and other	30,679	(575)	(23)
Changes, net of acquisitions, in:
Accounts receivable	(10,551)	(6,947)	(1,308)
Factor accounts receivable	39,674	(31,542)	(18,647)
Inventories	4,425	(30,567)	25,303
Prepaid expenses, income tax receivables, prepaid taxes, and other assets	(8,314)	133	(1,060)
Accounts payable and accrued expenses	9,891	37,339	7,052
Accrued incentive compensation	(8,833)	3,118	280
Leases and other liabilities	(3,939)	(6,979)	(8,061)
Payment of contingent liability	0	0	(1,153)
Net cash provided by operating activities	162,199	198,096	229,237
Cash flows from investing activities:
Acquisition of businesses	(371,554)	(13,976)	(75,271)
Capital expenditures	(42,658)	(25,911)	(19,470)
Purchases of short-term investments	0	(21,405)	(25,688)
Maturity/sale of short-term investments	13,553	22,139	25,872
Other investing activities	(260)	(340)	(5,335)
Net cash used in investing activities	(400,919)	(39,493)	(99,892)
Cash flows from financing activities:
Borrowings under credit facilities	467,500	0	0
Repayments under credit facilities	(227,500)	0	0
Cash dividends paid on common stock	(60,962)	(61,039)	(63,177)
Common stock repurchased and net settlements of stock awards	(13,523)	(98,433)	(142,348)
Financing costs paid	(8,955)	0	0
Investment of noncontrolling interest	3,500	0	4,486
Distributions to noncontrolling interest earnings	2,946	0	1,102
Proceeds from exercise of stock options	32	1,613	1,205
Acquisition of incremental ownership of joint ventures	0	(1,500)	0
Payment of contingent liability	0	(8,547)	0
Net cash provided by / (used in) financing activities	157,146	(167,906)	(200,936)
Effect of exchange rate changes on cash and cash equivalents	4,073	(5,413)	1,518
Net change in cash and cash equivalents	(77,501)	(14,716)	(70,073)
Cash and cash equivalents – beginning of year	189,924	204,640	274,713
Cash and cash equivalents – end of year	112,423	189,924	204,640
Supplemental disclosure of cash flow information:
Cash paid during the year for interest	$ 11,699	$ 0	$ 0